We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Science & Health

Women in Cannabis Study Now Available to Women in the UK

Published: Feb 05, 2020   

Complete the form below and we will email you a PDF version of "Women in Cannabis Study Now Available to Women in the UK"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Women in Cannabis Study Now Available to Women in the UK

Ladyjane Branding and Wolfe Research & Consulting are pleased to announce that the Women in Cannabis Study is now open for respondents who work in the cannabis industry in the United Kingdom.

The UK portion of the study, which is already receiving responses from women in the United States and Canada, will be disseminated and analyzed in partnership with Dr Callie Seaman, a veteran member of the hydroponics industry and early advocate of the medical cannabis movement in the United Kingdom.

While recreational cannabis still remains illegal in the country, medical cannabis was legalized in the UK in November of 2018, although the medical cannabis system has been slow to start up. Nevertheless, the study partners are eager to understand the experiences of women in the emerging cannabis industry in the UK. To do this, the study will explore women’s thoughts on opportunities for leadership, mentorship, and raising capital while also looking at life/work balance, and the role of cannabis in their lives and in the workplace.

The survey is largely quantitative as the study partners seek to add data to women’s experiences, but those who have qualitative feedback to share will be invited to submit written feedback or participate in a telephone interview.

“Dr Callie Seaman’s expertise and long-standing position within the emergent cannabis industry in the UK makes her a perfect partner to carry out the UK portion of this study”, said Jennifer Whetzel of Ladyjane Branding.

Seaman first became passionate about medical cannabis when she was diagnosed with epilepsy over 20 years ago. Eager to learn more about how cannabinoids can affect human health, she pursued a degree in biomedical sciences, and then went on to complete a PhD on the hydroponic growth of plants, both at Sheffield Hallam University. Her educational experiences led her to become the founding director of Aqua Laboratories Limited, which formulates and produces hydroponic nutrients.

Her passion for the medicinal properties of plants led her to become involved with a CBD producer in the UK, while she also acts as a consultant for licensed producers who are getting their facilities up and running. She is also scientific co-director of the educational program CANNTalks: A Conversation on Cannabis at Cambridge University.

“Seaman is well-connected within the UK cannabis industry and will provide outstanding leadership for women within the UK by encouraging them to participate in this study,” said Whetzel, “We couldn’t be more thrilled to include her amongst our robust group of study partners.”

The Women in Cannabis Study is available at www.womenincannabis.study and will be open for responses until March 1, 2020.


This article has been republished from material provided by Ladyjane Branding. Note: material may have been edited for length and content. For further information, please contact the cited source.

 

Like what you just read? You can find similar content on the topic tag shown below.

Science & Health

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement